Eastern Bank’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.1K Buy
1,782
+1
+0.1% +$12 ﹤0.01% 736
2026
Q1
$10.7K Sell
1,781
-529
-23% -$3.98K ﹤0.01% 837
2025
Q4
$16.6K Sell
2,310
-141
-6% -$1.11K ﹤0.01% 764
2025
Q3
$26.2K Buy
2,451
+21
+0.9% +$206 ﹤0.01% 677
2025
Q2
$23.5K Sell
2,430
-47
-2% -$485 ﹤0.01% 656
2025
Q1
$36.9K Sell
2,477
-280
-10% -$4.31K ﹤0.01% 587
2024
Q4
$41.1K Sell
2,757
-120
-4% -$1.96K ﹤0.01% 593
2024
Q3
$55K Buy
+2,877
New +$59.6K ﹤0.01% 550
2021
Q3
Sell
-10,568
Closed -$319K 191
2021
Q2
$319K Buy
+10,568
New +$348K 0.02% 169

Other funds holding OGN

Eastern Bank's OGN Position: Q2 2026 in Review

Eastern Bank increased its Organon & Co (OGN) stake by 0.06% in Q2 2026, buying an estimated $12 and bringing the position to 1,782 shares worth $24.1K. The position accounts for ﹤0.01% of the portfolio, ranked #736.

Eastern Bank first reported a position in OGN in Q2 2021 and has held it in 9 quarters since. The position peaked at $319K in Q2 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Eastern Bank held 1,782 shares of Organon & Co worth $24.1K as of Q2 2026.
  • Eastern Bank bought 1 Organon & Co share in Q2 2026, an estimated $12.
  • Organon & Co made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #736 holding.
  • Eastern Bank first reported a position in Organon & Co in Q2 2021 and has held it in 9 quarters since.
  • Eastern Bank's Organon & Co position peaked at $319K in Q2 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.